Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI turns low-quality MRI scans into helpful heart images
A team of biomedical engineers, radiologists and cardiologists has developed a new AI model capable of restoring low-quality cardiac MRI scans.
Johnson & Johnson MedTech faces threat of permanent injunction after losing antitrust case
After being ordered to pay $442 million in damages—a ruling the company has said it may appeal—Johnson & Johnson MedTech is now facing the possibility of a permanent injunction that could impact certain business practices. A hearing is scheduled for July.
Cardiologists, radiologists and surgeons share ‘landmark’ document on assessing prosthetic heart valves with CT
RSNA and several other industry societies have shared a new expert consensus document on the significant value of cardiac CT. Echo remains an effective first-line imaging option, the groups wrote, but CT can make a big impact as well.
AMA resolution backs expanded low-dose CT screenings for lung cancer, heart risk
Dana Smetherman, MD, CEO of the American College of Radiology, discusses the policy, which urges for more robust promotion of low-dose CT as a public health tool.
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.

Charalambos Antoniades, MD, the British Heart Foundation Chair of Cardiovascular Medicine at the University of Oxford, is a co-founder of the company Caristo, which has developed technology to image coronary inflammation on coronary computed tomography angiography (CCTA) scans to visualize a key factor of residual cardiovascular risk.

Detecting coronary inflammation on CT imaging could reshape preventive cardiology

New technology now being considered by the FDA for approval can capture coronary inflammation on CCTA images and provide risk assessments. What could this mean for the future of cardiac care? We spoke to one researcher to learn more.

The new cardiac PET radiotracer flurpiridaz F-18 is posed to be a major game changer and will likely lead to increased adoption of cardiac PET.

‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.

Newsweek ranked the 50 best heart hospitals in the world

Know your options: What cardiologists recommend when alternative access is required for TAVR

Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement.

Heartflow artificial intelligence CCTA images

AI leader Heartflow enters new era focused on delivering personalized care for CAD patients

The company's AI-powered CCTA assessments have already been used to help manage more than 400,000 heart patients around the world.

Cardiovascular societies support Medicare coverage for renal denervation

CMS is expected to release a proposed national coverage determination decision memo by July.

Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced.

Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiac Imaging

AI turns low-quality MRI scans into helpful heart images

Johnson & Johnson MedTech faces threat of permanent injunction after losing antitrust case

Cardiologists, radiologists and surgeons share ‘landmark’ document on assessing prosthetic heart valves with CT

AMA resolution backs expanded low-dose CT screenings for lung cancer, heart risk

Angiographic catheters recalled due to safety risk